EVN
Director Trades
| Date | Director | Value |
|---|---|---|
| J. Klein | $36,542,855 |
Company News
Gold and Silver Hit Record Highs – What it Means for ASX Gold Stocks
Gold and silver surged to fresh record highs on Monday, buoyed by a weakening US dollar and growing expectations that the US Federal Reserve will cut interest rates later this month. The London Bullion Market Association set its afternoon auction benchmark for gold at US$3,475 per troy ounce (A$5,350/oz), surpassing the previous record set in […]
Evolution Mining targets more than $1.9b annual cash flow on the back of strong drilling results
Evolution Mining’s (ASX: EVN) ambitious growth plans continue to gather momentum with further drilling successes across its portfolio. The latest results have boosted the company’s confidence in the upside potential at its Ernest Henry, Northparkes and Cowal operations. Evolution is now on track to record more than $1.9 billion in operating cash flow for the […]
Evolution Mining rides gold price surge to record FY24 earnings and dividend increase
Australian gold and copper miner Evolution Mining (ASX: EVN) has delivered record earnings alongside strong cash generation during the 2024 financial year. Boosted by robust commodity prices, the company successfully increased its EBITDA margin to 47% and lifted group cash flow to $367.3 million, despite investing $739.6m back into the business. Evolution’s FY24 success saw […]
An investors guide to the 2023 Diggers & Dealers mining forum
Investors looking for small-cap mining companies with a bright future discover every year that the best place to find them is also the most difficult. Australia’s remote gold, nickel and rare earth capital, Kalgoorlie in Western Australia, is where there will next week be a concentration of mining company managers at the annual Diggers and […]
Rio Tinto’s US$3.3b bid wins over Turquoise Hill board, AMP loses control of key trust and James Hardie gains new CEO
Mining giant Rio Tinto (ASX: RIO) has successfully won over the board of Canada’s Turquoise Hill Resources with its takeover offer of US$3.3 billion (A$4.84 billion) to acquiring the company’s remaining 49% stake. The revised US$3.3 billion offer trumps the US$2.7 billion previously on the table, which the Canadian miner turned away. Acquiring full ownership […]
Ventia awarded NZ road maintenance contract, CSL to acquire Vifor Pharma and A2 Milk closer to exporting to US
Ventia Services (ASX: VNT) has been awarded a road maintenance contract by Auckland Transport for New Zealand’s Auckland West region. The contract term is for five years and is set to commence on 1 September and generate a base value of NZ$220 million across the initial term. It has an option to be extended for […]
Navarre Minerals reveals more high-grade gold, silver and copper at Mt Carlton United
Navarre Minerals (ASX: NML) has uncovered more high-grade gold, silver and copper while drilling at its Mt Carlton United deposit in North Queensland. The latest batch of results comprise 8,989 metres of drilling completed in 92 reverse circulation (RC) and 14 diamond core holes. One of the best intersections measured 1m grading 196.1 grams per […]
Andrew ‘Twiggy’ Forrest gets a taste for gold
Follow the rich is always a good investment strategy, as was shown last year when iron ore billionaire Gina Rinehart moved early into oil and gas, and why another iron ore billionaire’s sudden interest in gold could deliver similar results. Andrew Forrest, founder and major shareholder of Fortescue Metals (ASX: FMG), has not previously been […]
Mining’s fork in the road: back the bold or follow the cautious
The old saying about fortune favouring the bold is being put to the test in Australia’s mining industry, with one gold producer choosing to expand in a climate of high and rising costs, while another opts for safety. The difference between Northern Star Resources (ASX: NST), which is planning a major investment, and Evolution Mining […]
Imugene reveals positive trial, Evolution Mining downgrades gold production forecast and BHP announces ‘nature positive’ pledge
Imugene’s (ASX: IMU) share price rocketed this week following the announcement its lead candidate HER-Vaxx increased the survival rate in patients with advanced gastric cancer. The clinical stage immuno-oncology company announced positive survival rates for its HER-Vaxx drug during a phase 2 clinical trial. HER-Vaxx is a B-cell immunotherapy candidate used for the treatment of […]
